Audiocast Library - Conference Correspondent
Jennifer Brown, MD, PhD
Jennifer Brown, MD, PhD, expanded upon the results of her and her colleagues’ study of the hepatotoxic effects of idelalisib, particularly as frontline treatment of younger patients with chronic lymphocytic leukemia, which was presented at the 57th American Society of Hematology Annual Meeting & Exposition.
Related Items
ASHP Foundation Forecast Provides Actionable Recommendations for Pharmacy Leaders
William A. Zellmer, BPharm, MPH
Audiocast Library published on February 19, 2016 in Conference Correspondent
Formulary Management and Procurement of Oncology Medications
Lindsey B Amerine, PharmD, MS, BCPS
Audiocast Library published on September 10, 2015 in Conference Correspondent
Intravenous Iron Better Tolerated Than Oral Iron for Chemotherapy-Induced Anemia
Gunnar Birgegård, MD, PhD
Audiocast Library published on September 10, 2015 in Conference Correspondent
Developing a Pharmacist-Driven Drug-Monitoring Protocol
Felicia Zook, PharmD, BCOP
Audiocast Library published on August 7, 2015 in Conference Correspondent
Meeting USP Chapter 800 Head On
Michael Koraleski, PharmD
Audiocast Library published on August 7, 2015 in Conference Correspondent
Last modified: May 6, 2016